Encapson’s lead product is Sono-Coat, which was developed to make medical devices, such as catheters and needles, better visible in the body under ultrasound imaging. Improving a device’s visibility under ultrasound allows a procedure to be carried out faster and more accurately. For several procedures Sono-Coat will allow X-ray imaging to be replaced with safer and cheaper ultrasound imaging.
This investment round will be used to further expand the companies manufacturing capabilities and clean room facilities in Enschede
Encapson ceo, Donato Di Biase, is excited about the investment. He said: “We have completely finished development of this unique technology and are now very busy working with our customers to coat their devices. With this new investment round we are able to speed this process up and to offer our customers an even higher level of service.”
TTF managing partner and Encapson supervisory board member, Harm de Vries, commented: “Since our first investment Encapson has developed a fantastic product portfolio and is working together with some very strong device manufacturers to perfect the coating on their specific devices and bring them into the market”
“This investment will lead to the introduction of several improved medical devices into the market, leading to better patient comfort and saving hospitals costs” said Bart Blokhuis, Innovation Fund Enschede fund manager. “This fits with the core goals of our fund and we are excited to join TTF and Encapson in this venture.”